John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He explains how this treatment has shown exceptional efficacy with limited side effects.

Chantel Hillestad, RN, MSN, DCNP, FNP-C: Restoring Pigmentation in Patients with Vitiligo
Ms. Hillestad describes the benefits she has seen in treating patients with ruxolitinib, specifically the success in providing repigmentation in all age groups.
PLAY